Award & Investment Overview
ClAIrVuE, a Tufts University spinout developing an AI-powered decision intelligence platform for organ transplant surgery, received the Audience Choice Award at the 19th annual Massachusetts Life Sciences Innovation (MALSI) Day, one of the Commonwealth’s premier showcases for emerging life sciences startups.
The company was one of five Tufts-affiliated ventures selected to participate in the Startup Pitch Showcase, where 28 early-stage life sciences companies presented technologies to investors, industry leaders, and entrepreneurs. Audience Choice recognition highlights growing market interest in ClAIrVuE’s approach to improving surgical decision-making through artificial intelligence.
The company is based on research led by Dr. Srivalleesha Mallidi, Associate Professor of Biomedical Engineering at Tufts University, who serves as Chief Scientific Officer. CEO Avijit Paul previously received a FY26 Tufts Launchpad | Accelerator award to advance the underlying AI-enabled photoacoustic imaging technology.
Approach & Ecosystem Context
ClAIrVuE demonstrates how university commercialization programs can accelerate the translation of biomedical engineering research into venture-backed healthcare technologies.
Support from Tufts Commercialization and the Tufts Launchpad | Accelerator helped move the technology beyond the laboratory while providing venture development resources that prepared the company for investor engagement and external validation. Recognition at MALSI Day illustrates the value of regional innovation ecosystems that connect university spinouts with investors, corporate partners, and experienced entrepreneurs.
From a Mind the GAP perspective, startup showcase events such as MALSI Day represent an important commercialization milestone. While they do not provide significant capital, they offer market validation, investor exposure, and credibility that can help early-stage university companies secure follow-on funding and strategic partnerships.
The strong Tufts representation at MALSI Day also reflects the university’s continued investment in building a sustainable commercialization pipeline for life sciences innovation.
Innovation & Technology
ClAIrVuE is developing an AI-powered decision intelligence platform that provides surgeons with real-time guidance during organ transplant procedures.
Initially focused on kidney transplantation, the platform combines artificial intelligence with photoacoustic imaging to deliver intraoperative safety alerts and predict delayed graft function before complications become clinically apparent.
By providing real-time decision support, the technology has the potential to improve transplant outcomes, reduce postoperative complications, and support more informed surgical decision-making.
Potential Market Uses and Applications
ClAIrVuE
Potential Clinical Applications
- Kidney transplantation
- Organ transplant surgery
- Intraoperative decision support
- Delayed graft function prediction
- Surgical workflow optimization
Potential Healthcare Applications
- Academic medical centers
- Transplant centers
- Surgical AI platforms
- Precision surgery
Potential Commercial Applications
- AI-enabled surgical software
- Clinical decision support platforms
- Hospital digital health solutions
- Transplant analytics
Related Topics
Tufts University, Tufts Commercialization, Tufts Launchpad Accelerator, university spinouts, digital health, artificial intelligence, organ transplantation, surgical AI, biomedical engineering, Massachusetts Life Sciences Innovation Day
About innovosource
innovosource tracks GAP programs, including proof-of-concept programs, startup accelerators, translational research initiatives, university venture funds, and commercialization ecosystems that help move university innovations from research to market.
Our coverage is informed by the Mind the GAP Initiative and the GAP COA consortium activity, providing practical insights into the evolving commercialization landscape.
Learn more:
Source
https://now.tufts.edu/2026/07/26/tufts-startup-clairvue-wins-audience-choice-award-malsi-day
